Helmholtz Zentrum München patents compounds for viral infections and cancer

AI Briefing

• – Helmholtz Zentrum München researchers develop new compounds for cancer and viral infection treatment
• – The compounds are designed to selectively target specific proteins involved in viral replication and cancer cell proliferation
• – The compounds are currently in the early stages of testing, with further research needed to confirm their safety and efficacy